C Papadimitriou

Overview

Explore the profile of C Papadimitriou including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 114

Citations 991

Followers 0

Related Specialties

Oncology

General Surgery

Gynecology & Obstetrics

Top 10 Co-Authors

M A Dimopoulos

G Fountzilas

P Kosmidis

D Bafaloukos

G Aravantinos

D Skarlos

A Bamias

P Papakostas

N Pavlidis

H P Kalofonos

Published In

Ann Oncol

Anticancer Res

J Clin Oncol

Urology

Bone Marrow Transplant

Affiliations

Soon will be listed here.

Recent Articles

11.

Y-box-binding protein 1 (YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse

Mylona E, Melissaris S, Giannopoulou I, Theohari I, Papadimitriou C, Keramopoulos A, et al.

Eur J Surg Oncol . 2013 Oct; 40(3):289-96. PMID: 24075827

Aims: To investigate the expression pattern of Y-box-binding protein 1 (YB1) in breast carcinomas, its clinicopathological and prognostic value, and its association with the breast cancer stem cell phenotype [CD44(+)/CD24(-/low)]....

12.

Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel

Koutras A, Kotoula V, Papadimitriou C, Dionysopoulos D, Zagouri F, Kalofonos H, et al.

Pharmacogenomics J . 2013 Sep; 14(3):248-55. PMID: 24061601

The aim of the study was to evaluate the association of vascular endothelial growth factor (VEGF) genotypes with treatment efficacy in a phase II trial. This study evaluated weekly docetaxel,...

13.

VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT

Terpos E, Christoulas D, Kastritis E, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, et al.

Leukemia . 2013 Sep; 28(4):928-34. PMID: 24045498

We prospectively evaluated the effect of bortezomib, thalidomide and dexamethasone (VTD) consolidation on bone metabolism of 42 myeloma patients who underwent an autologous stem cell transplantation (ASCT). VTD started on...

14.

Structure and function of the oncologic boards in Greece. Description of the institutional and scientific frame; objective problems and difficulties

Zygogianni A, Syrigos K, Mistakidou K, Fotineas A, Kyrgias G, Ferendouros V, et al.

J BUON . 2013 Apr; 18(1):281-8. PMID: 23613417

Purpose: Oncology boards should constitute a routine in all hospitals that are dealing with the care of cancer patients. Unfortunately the procedure which should be followed to deal with this...

15.

A test for adequate wastewater treatment based on glutathione S transferase isoenzyme profile

Grammou A, Samaras P, Papadimitriou C, Papadopoulos A

Ecotoxicol Environ Saf . 2013 Jan; 90:46-51. PMID: 23313117

Discharge to the environment of treated or non-treated municipal wastewater imposes several threats to coastal and estuarine ecosystems which are difficult to assess. In our study we evaluate the use...

16.

Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies

Murray S, Briasoulis E, Linardou H, Bafaloukos D, Papadimitriou C

Cancer Treat Rev . 2012 Apr; 38(7):890-903. PMID: 22465195

Background: Taxanes are established in the treatment of metastatic breast cancer (MBC) and early breast cancer (EBC) as potent chemotherapy agents. However, their therapeutic usefulness is limited by de-novo refractoriness...

17.

The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer

Avraam K, Pavlakis K, Papadimitriou C, Vrekoussis T, Panoskaltsis T, Messini I, et al.

Eur J Gynaecol Oncol . 2011 Nov; 32(5):516-20. PMID: 22053665

Aim: To evaluate the expression of ERCC-1 in patients with epithelial ovarian cancer (EOC) and to correlate it with the expression of p53, bcl-2 and bax. Materials And Methods: Tumor...

18.

Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitro

Oelmann E, Topp M, Reufi B, Papadimitriou C, Koenigsmann M, Oberberg D, et al.

Int J Oncol . 2011 May; 4(3):555-8. PMID: 21566958

In this study we report that recombinant human (rh) interleukin-1alpha (IL-1alpha) has direct and dose-dependent growth-modulating effects on human tumor cell lines in vitro as measured by a human tumor...

19.

Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34(+) hematopoietic cells

Papadimitriou C, Roots A, Koenigsmann M, Oelmann E, Topp M, Oberberg D, et al.

Int J Oncol . 2011 May; 9(6):1107-12. PMID: 21541618

Immunomagnetic separation using anti-CD34 monoclonal antibodies and paramagnetic microspheres has been used to enrich hematopoietic stem cells from human bone marrow, whole cord blood, or mobilized peripheral blood mononuclear cell...

20.

Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerations

Pallis A, Briasoulis E, Linardou H, Papadimitriou C, Bafaloukos D, Kosmidis P, et al.

Curr Med Chem . 2011 Mar; 18(11):1613-28. PMID: 21428885

Non-Small-Cell Lung Cancer (NSCLC) with somatic mutations of the epidermal growth factor receptor (EGFR) is anticipated to respond to small-molecule tyrosine kinase inhibitors (TKIs) of the EGFR tyrosine kinase. There...